发明名称 Use of eicosapentaenoic acid or docosahexaenoic acid or fish oil for prevention of cerebral damage in patients having symptoms of atherosclerosis or arteries supplying the brain i.e stroke
摘要 Disclosed is the use of the n-3 PUFA EPA and DHA in the preparation of an oral medicament for preventing cerebral damage in patients having symptoms of atherosclerosis of arteries supplying the brain.
申请公布号 NZ536507(A) 申请公布日期 2008.12.24
申请号 NZ20030536507 申请日期 2003.05.02
申请人 PRONOVA BIOPHARMA NORGE AS 发明人 CALDER, PHILIP;GRIMBLE, ROBERT;GALLAGHER, PATRICK;SHEARMAN, CLIFF
分类号 A23L1/30;A61K9/48;A61K31/202;A61K31/232;A61P7/00;A61P9/10 主分类号 A23L1/30
代理机构 代理人
主权项
地址